Dianthus Therapeutics, Inc.
DNTHNasdaqCIK 1690585HealthcareFiscal year ends Dec 31
Reports and events: 154 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-02-0716:52 ET | S-1/A | Registration statement, amended | 0001193125-24-026760 |
| 2024-01-3112:11 ET | SC 13D | Ownership report, active investor | 0000919574-24-000598 |
| 2024-01-2417:26 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-014361 |
| 2024-01-2207:34 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-011681 |
| 2024-01-0808:02 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-24-002707 |
| 2023-12-2117:08 ET | S-1/A | Registration statement, amended | 0001193125-23-301290 |
| 2023-12-2116:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-301206 |
| 2023-11-0916:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-062070 |
| 2023-11-0916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-062034 |
| 2023-10-2516:15 ET | 8-K | 4.01 Change of auditor | 0000950170-23-055193 |
| 2023-09-2116:34 ET | SC 13D | Ownership report, active investor | 0001193125-23-239627 |
| 2023-09-2116:32 ET | SC 13D | Ownership report, active investor | 0001193125-23-239624 |
| 2023-09-2121:50 ET | 8-K/A | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-238850 |
| 2023-09-1516:56 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-23-101247 |
| 2023-09-1216:05 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.05 Item not in the standard list; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-233448 |
| 2023-09-0817:19 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events | 0001193125-23-231669 |
| 2023-08-0308:01 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-037605 |
| 2023-05-1916:21 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-23-149353 |
| 2023-05-1516:06 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-022192 |
| 2023-05-0307:44 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-133205 |
| 2023-05-0108:31 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001193125-23-128874 |
| 2023-04-0608:27 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement | 0001193125-23-093153 |
| 2023-03-3116:37 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-088185 |
| 2023-03-2308:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-009331 |
| 2023-02-0716:12 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors | 0001193125-23-026931 |
| 2023-02-0217:02 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-022825 |
| 2023-01-2516:09 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-23-015154 |
| 2022-12-2009:05 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-308821 |
| 2022-12-1308:36 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-303275 |
| 2022-11-0309:14 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021603 |
| 2022-11-0309:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-276477 |
| 2022-08-1708:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-222823 |
| 2022-08-0408:28 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001193125-22-211881 |
| 2022-08-0408:24 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-211873 |
| 2022-06-3016:01 ET | 8-K | 5.07 Shareholder vote results | 0001193125-22-186149 |
| 2022-05-1609:09 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001193125-22-151014 |
| 2022-05-1609:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-151011 |
| 2022-05-0516:01 ET | SC 13D/A | Ownership report, active investor, amended | 0001387131-22-005741 |
| 2022-05-0216:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-136748 |
| 2022-05-0216:01 ET | DEF 14A | Proxy statementPeriod 2022-06-28 | 0001193125-22-136711 |
| 2022-04-1408:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-22-105004 |
| 2022-03-0808:31 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001193125-22-068759 |
| 2022-03-0808:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-068757 |
| 2022-01-1008:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-22-005128 |
| 2021-11-0409:13 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001193125-21-319502 |
| 2021-11-0409:10 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-21-319497 |
| 2021-08-0508:17 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001193125-21-237060 |
| 2021-08-0508:12 ET | 8-K | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-21-237056 |
| 2021-07-2716:55 ET | 8-K | 2.02 Results of operations | 0001193125-21-225843 |
| 2021-06-0708:09 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results | 0001193125-21-183770 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 4, 2026, 16:45 ET. Listed shows no prices and gives no investment advice.